Direction for use: After initial priming of the Axcel Mometasone 0.05%w/w Nasal Spray (Usually 10 actuation, until a uniform spray is observed), each actuation delivers approximately 100mg of mometasone furoate suspension, containing mometasone furoate monohydrate equivalent to 50mcg mometasone furoate. If the spray pump has not been used for 14 days or longer, it should be reprimed with 2 actuations, until a uniform spray is observed, before next use.
Shake container well before each use.
Seasonal allergic or perennial rhinitis: Adults (including geriatric patients) and adolescents: The usual recommended dose for prophylaxis and treatment is two sprays (50mcg/spray) in each nostril once daily (total dose 200mcg). Once symptoms are controlled, dose reduction to one spray in each nostril (total dose 100mcg) may be effective for maintenance. If symptoms are inadequately controlled, the dose may be increased to a maximum daily dose of four sprays in each nostril once daily (total dose 400mcg). Dose reduction is recommended following control of symptoms. Clinically significant onset of action occurs as early as 12 hours after the first dose.
Children between the ages of 3 and 11 years: The usual recommended dose is one spray (50mcg/spray) in each nostril once daily (total dose 100mcg). Administration to young children should be aided by an adult.
Acute Rhinosinusitis: Adults (including Geriatric Patients) and adolescents ≥ 12 years: The usual recommended dose for acute rhinosinusitis is two actuations (50 micrograms/actuation) in each nostril twice daily (total daily dose of 400 micrograms). If no improvement is seen after 15 days of twice daily administration, alternative therapies should be considered. If symptoms worsen during treatment, the patient should be advised to consult their physician.
Nasal polyposis: Adults (including geriatric patients) and adolescents 18 years of age and older: The usual recommended dose for polyposis is two sprays (50mcg/spray) in each nostril twice daily (total daily dose of 400mcg). Once symptoms are adequately controlled, dose reduction to two sprays in each nostril once daily (total daily dose 200mcg) is recommended.
Method of administration: Route: For intranasal administration only.